Xilio Therapeutics Announces Initiation of Enrollment for Ph

Phase 1 combination dose escalation expected to support planned Phase 2 trial in microsatellite stable colorectal cancer Updated Phase 1 monotherapy data for XTX101 at the recommended Phase 2 dose...

Related Keywords

China , Melissa Forst , Julissa Viana , Katarina Luptakova , Corporate Communications , Linkedin , Genentech United States Inc , European Society For Medical Oncology , Exchange Commission , Roche Group , Nasdaq , Clinical Development , Oncology Congress On , Oncology Congress , Xilio Therapeutics Inc , European Society , Medical Oncology , Immuno Oncology Congress , Ongoing Phase , Development Plans , Regarding Forward Looking , Private Securities Litigation Reform Act , Quarterly Report , Genentech United States , Media Inquiries , Investor Relations , Markets ,